Product Highlight - OVERT

25 Nov 2021
Product Highlight - OVERT
ZerOVERTIGO

• Betahistine is used to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere’s disease.

• The usual initial dose is 8 mg to 16 mg three times daily taken preferably with meals; maintenance doses are generally in the range of 24 to 48 mg daily.

Reference:
Full product insert of Overt.



Related MIMS Drugs

Editor's Recommendations